Rezolute RZLT
NASDAQ RZLT
$4.58 +0.04 (+0.88%)
As of: Sep 4, 2026 · 3:59 PM EDT

Rezolute (RZLT) Change in Accured Expenses (2012 - 2026)

Rezolute (RZLT) posted Change in Accured Expenses of -$1.4 million for Q1 2026, down 2.23% sequentially from -$1.4 million in Q4 2025, and up 60.66% YoY from -$883232.6 in Q1 2025.

Analysis

Rezolute (RZLT) Change in Accured Expenses (2012 - 2026) Analysis & Trends

Rezolute has reported Change in Accured Expenses for 15 years, with the latest figure at -$1.4 million in Q1 2026.

  • Quarterly Change in Accured Expenses rose 60.66% year-over-year to -$1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$238000.0 (down 158.7% YoY) and the FY2025 annual result came in at $721000.0, down 66.4% from the prior year.
  • Change in Accured Expenses retreated to -$1.4 million in Q1 2026 per RZLT's latest filing, from -$1.4 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $2.7 million in Q3 2023 and troughed at -$3.6 million in Q1 2025.
  • A 5-year average of $3058.8 and a median of -$42000.0 in 2022 frame the typical range for Change in Accured Expenses.
  • The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses plunged 275.0% in 2022, then soared 6550.0% in 2023.
  • Over 5 years, Change in Accured Expenses stood at $2.1 million in 2022, then slumped by 125.74% to -$540000.0 in 2023, then jumped by 373.7% to $1.5 million in 2024, then plunged by 193.91% to -$1.4 million in 2025, then dropped by 2.23% to -$1.4 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$1.4 million, -$1.4 million, and $667000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 222.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 492.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 11.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 55.78 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 212.44 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 61.62 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 68.82 Mn
10 Rezolute 477.02 Mn 477.02 Mn - -1.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.42 Mn
Dec 31, 2025 -1.39 Mn
Sep 30, 2025 667,000.00
Jun 30, 2025 1.90 Mn
Mar 31, 2025 -3.61 Mn
Dec 31, 2024 1.48 Mn
Sep 30, 2024 948,000.00
Jun 30, 2024 1.09 Mn
Mar 31, 2024 -1.11 Mn
Dec 31, 2023 -540,000.00
Sep 30, 2023 2.71 Mn
Jun 30, 2023 373,000.00
Mar 31, 2023 -2.22 Mn
Dec 31, 2022 2.10 Mn
Sep 30, 2022 -42,000.00
Jun 30, 2022 -78,000.00
Mar 31, 2022 -802,000.00
Dec 31, 2021 1.09 Mn
Sep 30, 2021 24,000.00
Jun 30, 2021 -21,000.00